| Alterations of choline phospholipid metabolism in ovarian tumor progression E Iorio, D Mezzanzanica, P Alberti, F Spadaro, C Ramoni, S D'Ascenzo, ... Cancer research 65 (20), 9369-9376, 2005 | 340 | 2005 |
| Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells E Iorio, A Ricci, M Bagnoli, ME Pisanu, G Castellano, M Di Vito, ... Cancer research 70 (5), 2126-2135, 2010 | 227 | 2010 |
| Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer M Bagnoli, S Canevari, D Mezzanzanica The international journal of biochemistry & cell biology 42 (2), 210-213, 2010 | 215 | 2010 |
| The Apoptosis Inhibitor Protein Survivin Induces Tumor-specific CD8+ and CD4+ T Cells in Colorectal Cancer Patients C Casati, P Dalerba, L Rivoltini, G Gallino, P Deho, F Rini, F Belli, ... Cancer research 63 (15), 4507-4515, 2003 | 183 | 2003 |
| Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection M Figini, L Obici, D Mezzanzanica, A Griffiths, MI Colnaghi, G Winter, ... Cancer research 58 (5), 991-996, 1998 | 152 | 1998 |
| The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells O Rosso, T Piazza, I Bongarzone, A Rossello, D Mezzanzanica, ... Molecular Cancer Research 5 (12), 1246-1253, 2007 | 140 | 2007 |
| IL-27 induces the expression of IDO and PD-L1 in human cancer cells G Carbotti, G Barisione, I Airoldi, D Mezzanzanica, M Bagnoli, S Ferrero, ... Oncotarget 6 (41), 43267, 2015 | 136 | 2015 |
| Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ... JNCI: Journal of the National Cancer Institute 107 (7), djv108, 2015 | 128 | 2015 |
| M‐CAM expression as marker of poor prognosis in epithelial ovarian cancer D Aldovini, F Demichelis, C Doglioni, D Di Vizio, E Galligioni, S Brugnara, ... International journal of cancer 119 (8), 1920-1926, 2006 | 124 | 2006 |
| MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer Y Sun, L Hu, H Zheng, M Bagnoli, Y Guo, R Rupaimoole, ... The Journal of pathology 235 (1), 25-36, 2015 | 120 | 2015 |
| The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma … FP Conde, R Orlandi, S Canevari, D Mezzanzanica, M Ripamonti, ... European journal of biochemistry 178 (3), 795-802, 1989 | 119 | 1989 |
| Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing LR Coney, D Mezzanzanica, D Sanborn, P Casalini, MI Colnaghi, ... Cancer research 54 (9), 2448-2455, 1994 | 114 | 1994 |
| Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients D Mezzanzanica, M Fabbi, M Bagnoli, S Staurengo, M Losa, E Balladore, ... Clinical Cancer Research 14 (6), 1726-1733, 2008 | 112 | 2008 |
| Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study M Bagnoli, S Canevari, D Califano, S Losito, M Di Maio, F Raspagliesi, ... The lancet oncology 17 (8), 1137-1146, 2016 | 110 | 2016 |
| Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction F Turatti, M Figini, E Balladore, P Alberti, P Casalini, JD Marks, ... Journal of immunotherapy 30 (7), 684-693, 2007 | 107 | 2007 |
| Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors) P Harter, D Gershenson, C Lhomme, F Lecuru, J Ledermann, ... International Journal of Gynecologic Cancer 24 (Supp 3), 2014 | 102 | 2014 |
| Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 LD Cecco, L Marchionni, M Gariboldi, JF Reid, MS Lagonigro, ... Oncogene 23 (49), 8171-8183, 2004 | 101 | 2004 |
| Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors I Ray-Coquard, J Brown, P Harter, DM Provencher, PC Fong, J Maenpaa, ... International Journal of Gynecologic Cancer 24 (Supp 3), 2014 | 96 | 2014 |
| Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells F Spadaro, C Ramoni, D Mezzanzanica, S Miotti, P Alberti, S Cecchetti, ... Cancer Research 68 (16), 6541-6549, 2008 | 96 | 2008 |
| Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications D Mezzanzanica, M Bagnoli, L De Cecco, B Valeri, S Canevari The international journal of biochemistry & cell biology 42 (8), 1262-1272, 2010 | 93 | 2010 |
